The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use

Схожие документы

• Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
  по: Wehring, Heidi J., et al.
  Опубликовано: (2011)
• Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia
  по: Koola, Maju Mathew
  Опубликовано: (2018)
• Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
  по: Correll, Christoph U., et al.
  Опубликовано: (2021)
• The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
  по: Miyamoto, Seiya, et al.
  Опубликовано: (2017)
• Psychiatric symptom differences in people with schizophrenia associated with substantial lifetime substance use but no current substance use disorder
  по: Koola, Maju Mathew, et al.
  Опубликовано: (2013)